Homocysteine in renal transplant recipients: Association with transplant duration and renal function

Renal Failure

Volumn 26, Issue 3, 2004, Pages 265-271

  Sobki, Samia H ^a   Khan, Shoukat A ^a   Al Mofawaz, Thekra A ^a   Saadeddin, Salam M ^a   Al Suliman, Mohammed ^a   Al Khader, Abdulla ^a  

^a The General Directorate of Armed Forces Health Services   (Saudi Arabia)

Author keywords

Homocysteine; Renal impairment; Renal transplant; Transplant duration

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; BILIRUBIN; CALCIUM; CHOLESTEROL; CREATININE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PHOSPHATE; POTASSIUM; SODIUM; TRIACYLGLYCEROL; UREA;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; GRAFT SURVIVAL; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RISK FACTORS;

EID: 3943064317     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-120039525     Document Type: Article

References (35)

1. Hannedouche, T.P.; Kunz, K.; Muller, S.; Chantrel, F. Homocysteine and chronic renal failure. In Advances in Nephrology; Mosby Inc., 1998; Vol. 28, 287-310. Chapter 12.
2. Mudd, S.H.; Levy, H.L. Plasma homocysteine or homocysteine (letter)? N. Engl. J. Med. 1995, 333, 325.
3. Dennis, V.W.; Robinson, K. Homocystinemia and vascular disease in end stage renal disease. Kidney Int. 1996, 50 (Suppl. 57), S11-S17.
4. Arnesen, E.; Refsum, H.; Bona, K.H.; Ueland, P.M.; Forde, O.H.; Nordrehaug, J.E. Serum total homocysteine and coronary heart disease. Int. J. Epidemiol. 1995, 24, 704-709.
5. Boushey, C.J.; Beresford, S.A.A.; Omenn, G.S.; Motulsky, A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 1995, 274, 1049-1057.
6. Chauveau, P.; Chadefaux, B.; Coude, M.; Aupetit, J.; Hannedouche, T.; Kamoun, P.; Jungers, P. Hyperhomocystinemia, a risk factor for atherosclerosis in chronic uremic patients. Kidney Int. 1993, 43 (Suppl. 41), S72-S77.
7. Robinson, K.; Gupta, A.; Dennis, V.; Arheart, K.; Chaudhary, D.; Green, R.; Vigo, P.; Mayer, E.; Selhub, J.; Kutner, M.; Jacobsen, D. Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations. Circulation 1996, 94, 2743-2748.
8. Bostom, A.G.; Lathrop, L. Hyperhomocystinemia in end stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int. 1997, 52, 10-20.
9. Ducloux, D.; Motte, G.; Challier, B.; Gibey, R.; Chalopin, J.M. Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients: a prospective study. J. Am. Soc. Nephrol. 2000, 11, 134-137.
10. Ducloux, D.; Ruedin, C.; Gibey, R.; Vautrin, P.; Bresson-Vautrin, C.; Rebibou, J.; Chalopin, J. Prevalence, determinants, and clinical significance of hyperhomocystinemia in renal-transplant recipients. Nephrol. Dial. Transplant. 1998, 13, 2890-2893.
11. Jungers, P.; Massy, Z.; Khoa, T.; Fumeron, C.; Labrunie, M.; Lacour, B.; Descamps-Latscha, B.; Man, N. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Nephrol. Dial. Transplant. 1997, 12, 2597-2602.
12. Bostom, A.G.; Gohh, R.Y.; Tsai, M.Y.; Hopkins-Garcia, B.J.; Nadeau, M.R.; Bianchi, L.A. Excess prevalence of fasting and post-methionine loading hyperhomocystinemia in stable renal transplant recipients. Arterioscler. Thromb. Vasc. Biol. 1997, 17, 1894-1900.
13. Dimeny, E.; Hultberg, B.; Wahlberg, J.; Fellstrom, B.; Arnadottir, M. Serum total homocysteine concentration does not predict outcome in renal transplant recipients. Clin. Transplant. 1998, 12, 563-568.
14. Stein, G.; Muller, A.; Busch, M.; Fleck, C.; Sperschneider, H. Homocysteine, its metabolites, and B-group vitamins in renal transplant patients. Kidney Int. 2001, 59 (Suppl. 78), S262-S265.
15. Arnadottir, M.; Hultberg, B.; Wahlberg, J.; Fellstrom, B.; Dimeny, E. Serum total homocysteine concentration before and after renal transplantation. Kidney Int. 1998, 54, 1380-1384.
16. Lindholm, A.; Albrectsen, D.; Frodin, L.; Tufvesson, G.; Persson, N.H.; Lundgren, G. Ischemic heart disease - a major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation 1995, 60, 451.
17. United States Renal Data System. USRDS. In Annual Data Report; The National Institute of Health: National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda MD, 1994.
18. Huh, W.; Kim, B.; Kim, S.J.; Kim, Y.G.; Kim, D.J.; Cho, J.W.; Oh, H.Y. Changes of fasting plasma total homocysteine in the early phase of renal transplantation. Transplant. Proc. 2000, 32, 2811-2813.
19. Fernandez-Miranda, G.; Gomez, P.; Diaz-Rubio, P.; Estenoz, J.; Carrillo, J.L.; Andres, A.; Morales, J.M. Plasma homocysteine levels in renal transplanted patients on cyclosporine or tacrolimus therapy: effect of treatment with folic acid. Clin. Transplant. 2000, 14, 110-114.
20. Krmar, R.T.; Ferraris, J.R.; Ramirez, J.A.; Galarza, C.R.; Waisman, G.; Janson, J.J.; Llapur, C.J.; Sorroche, P.; Legal, S.; Camera, M. Hyperhomocystinemia in stable pediatric, adolescents, and young adult renal transplant recipients. Transplantation 2001, 71, 1748-1751.
21. Arnadottir, M.; Hultberg, B.; Vladov, V.; Nilsson-Ehle, P.; Thysell, H. Hyperhomocystinemia in cyclosporine-treated renal transplant recipients. Transplantation 1996, 61, 509-512.
22. Bostom, A.; Gohh, R.; Bausserman, L.; Hakas, D.; Jacques, P.; Selhub, J.; Dworkin, L.; Rosenberg, I. Serum cysteine C as a determinant of fasting total homocysteine levels in renal transplant recipients with a normal serum creatinine. J. Am. Soc. Nephrol. 1999, 10, 164-166.
23. Shaw, J.; McWhinney, B.; Tate, J.; Resting, J.; Marczak, M.; Purdie, D.; Gibbs, H.; Cameron, D.; Hickman, P. Plasma homocysteine levels in indigenous Australians. Med. J. Aust. 1999, 170, 19-22.
24. Bunout, D.; Petermann, M.; de la Maza, P.; Kauffmann, R.; Suazo, M.; Hirsch, S. Serum homocysteine levels in healthy Chilean adults. Rev. Med. Chile 1998, 126, 905-910.
25. Pastore, A.; Massoud, R.; Motti, C.; Lo-Russo, A.; Fucci, G.; Cortese, C.; Federici, G. Fully automated assay for total homocysteine, cysteine, cysteinylglycine glutathione, cysteamine, and 2-mercaptopropionylglycine in plasma and urine. Clin. Chem. 1998, 44, 825-832.
26. Tonstad, S. Correlates of plasma total homocysteine in patients with hyperlipidemia. Eur. J. Clin. Investig. 1997, 27, 1025-1029.
27. Lussier-Cacan, S.; Xhignesse, M.; Piolot, A.; Selhub, J.; Davignon, J.; Genest, J., Jr. Plasma total homocysteine in healthy subjects: sex-specific relation with biological traits. Am. J. Clin. Nutr. 1996, 64, 587-593.
28. Massy, Z.A.; Chadefaux, V.B.; Chavalier, A.; Bader, C.A.; Drueke, T.B.; Legendre, C.; Lacour, B.; Kamoun, P.; Kreis, H. Hyperhomocystinemia: a significant risk factor for cardiovascular disease in renal transplant recipients. Nephrol. Dial. Transplant. 1994, 9, 1103-1108.
29. Hultberg, B.; Anderson, A.; Sterner, G. Plasma homocysteine in renal failure. Clin Nephrol. 1993, 40, 230-235.
30. Janssen, M.J.; van den Berg, M.; Stehouwer, C.D.; Boers, G.H. Hyperhomocystinemia: a role in the accelerated atherogenesis of chronic renal failure. Neth. J. Med. 1995, 46, 244-251.
31. Selhub, J.; Miller, J.W. The pathogenesis of homocystinemia: interruption of the coordinate regulation by s-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am. J. Clin. Nutr. 1992, 55, 131-138.
32. Bostom, A.; Gohh, R.; Beaulieu, A.; Nadeau, M.; Hume, A.; Jacques, P.; Selhub, J.; Rosenberg, I. Treatment of hyperhomocystinemia in renal transplant recipients. A randomized, placebo-controlled trial. Ann. Intern. Med. 1997, 127, 1089-1092.
33. Arnadottir, M.; Hultberg, B. Treatment with high dose folic acid effectively lowers plasma homocysteine concentration in cyclosporin-treated renal transplant recipients. Transplantation 1997, 64, 1087.
34. Wilken, D.E.L.; Gupta, V.J.; Betts, A.K. Homocysteine in the plasma of renal transplant recipients: effects of cofactors for methionine metabolism. Clin. Sci. 1981, 61, 743.
35. Sprung, J.; Kapural, L.; Bourke, D.L.; O'Hara, J.F. Anesthesia for kidney transplant surgery. Anesthesiol. Clin. North Am. 2000, 18, 919-951.